Table 3.
Other parameters of clinical outcome
Control | Exercise | Exercise + Diet | |||||||
---|---|---|---|---|---|---|---|---|---|
Before | After | p-value | Before | After | p-value | Before | After | p-value | |
Arms Extensors (N) | 105,13 ± 46,27 | 107 ± 103,21 | 0,8125 | 46,11 ± 84,42 | 55,36 ± 76,91 | 0,3125 | 96,86 ± 96,02 | 87,4 ± 101,1 | 0,4609 |
Arms Flexors (N) | 104,48 ± 106,84 | 123,38 ± 80,9 | 0,5469 | 74,8 ± 79,88 | 64,74 ± 59,54 | 0,25 | 97,65 ± 79,4 | 89,03 ± 78,78 | 0,1953 |
Legs Extensors (N) | 164,23 ± 111,47 | 185,95 ± 120,07 | 0,5469 | 136,62 ± 186,13 | 148,5 ± 81,51 | 0,3125 | 179 ± 199,61 | 152,86 ± 248,1 | 0,9453 |
Legs Flexors (N) | 120,87 ± 85,22 | 94,88 ± 74,49 | 0,9375 | 80,62 ± 79,91 | 55,5 ± 47,26 | 0,2109 | 67,7 ± 33,84 | 79,73 ± 60,5 | 0,3125 |
CK (U/L) | 280 ± 257 | 279 ± 284 | 0,2383 | 258 ± 262 | 371 ± 213 | 0,4131 | 272,5 ± 218 | 255 ± 104 | 0,1406 |
LDH (U/L) | 322 ± 209 | 325 ± 215 | 0,1367 | 320 ± 218 | 320 ± 257 | 0,2012 | 303 ± 278 | 261,5 ± 240 | 0,0469 |
6MWT (m) | 404 ± 93 | 412 ± 127 | 0,4258 | 425 ± 151 | 420 ± 152 | 0,166 | 416,8 ± 129 | 409 ± 119,2 | 1 |
VC (%) | 70 ± 33 | 71 ± 31 | 0,1797 | 71 ± 42 | 71 ± 48,5 | 0,9844 | 75 ± 42 | 89,5 ± 44 | 0,0625 |
FEV1 (%) | 70 ± 33 | 71 ± 38 | 0,3789 | 71 ± 42 | 72,4 ± 39,5 | 0,4844 | 66,5 ± 53 | 85 ± 49 | 0,0391 |
Data are expressed as median ± interquartile range before and after each intervention period
6MWT maximum walking distance measured by the 6 min walking test
VC vital capacity, FEV1 forced expiratory volume in 1 s